https://www.flexjobs.com/remote-jobs/company/soligenix
Soligenix - Remote Work From Home Jobs & Careers | FlexJobs
Find remote work from home jobs and careers with Soligenix. Get a better remote job search with FlexJobs today!
remote work from home jobscareersflexjobs
https://finviz.com/quote?t=SNGX&ty=c&ta=1&p=d
SNGX - Soligenix Inc Stock Price and Quote
SNGX - Soligenix Inc - Stock screener for investors and traders, financial visualizations.
stock pricesngxincquote
https://www.soligenix.com/
Late-Stage Biopharmaceutical Company | Soligenix
Apr 28, 2026 - Soligenix is a late-stage biopharmaceutical company that develops and commercializes products that treat rare diseases.
late stagebiopharmaceuticalcompany
https://clival.com/news/us-fda-awards-26-million-orphan-products-development-grant-to-soligenix-for-expanded-study-of-hybryte-to-treat-ctcl
US FDA awards $2.6 million orphan products development grant to Soligenix for expanded study of...
Here you get latest update about US FDA awards $2.6 million orphan products development grant to Soligenix for expanded study of HyBryte to treat CTCL.
https://www.ldmicro.com/profile/sngx/news/7762059814862083
Soligenix Inc. (Nasdaq: SNGX) :: LD Micro
Read this press release and other recent news about Soligenix Inc. (SNGX) at ldmicro.com
incnasdaqsngxldmicro
https://www.stockstobuynow.com/soligenix-inc-nasdaq-sngx-advances-civax-amid-ongoing-covid-19-threat/
Soligenix Inc. (NASDAQ: SNGX) Advances CiVax Amid Ongoing COVID-19 Threat - StocksToBuyNow
Apr 21, 2025 - Despite the passage of time since the pandemic, COVID-19 continues to pose a significant global health threat. Recent data from the World Health Organization...
https://www.fiercevaccines.com/tags/soligenix/
Soligenix - FierceVaccines
https://www.newsworthy.ai/curated/soligenix-reports-positive-clinical-data-for-ctcl-treatment-hybr/202630992
Soligenix Reports Positive Clinical Data for CTCL Treatment HyBryte | Newsworthy.ai
Soligenix Inc. provides encouraging interim analysis from its phase 3 FLASH2 study and positive comparative results for HyBryte therapy against existing...
clinical datareportspositive
https://www.financial-news.co.uk/soligenix-nasdaq-sngx-highlights-patient-centric-drug-development-strategy-through-reformulation-approach/
Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation...
Apr 21, 2026 - Austin, Texas, United States, 21st April 2026, FinanceWire
drug developmentnasdaqsngxhighlightspatient
https://faqstaq.news/news/202512/354228-faq-soligenixs-sgx302-phase-2a-psoriasis-study-results
FAQ: Soligenix's SGX302 Phase 2a Psoriasis Study Results | FaqStaq.News
study resultsfaqphase